(1 - 12 von 12
)
FDA Approves Praxbind® (idarucizumab), Specific Reversal Agent ...www.zhongqinews.com › 文传商讯
www.zhongqinews.com
· Boehringer Ingelheim Corporate Communications Media + PR Friederike Middeke Phone: + – Fax: + –
Spiolto® Respimat® enables greater physical activity in people living...
www.businesswirechina.com
Boehringer Ingelheim Corporate Communications Media + PR Friederike Middeke
Favorable safety profile of Pradaxa® (dabigatran etexilate) confirmed...
middleeastnewsroom.wixsite.com
· ... GmbH Corporate Communications Media + PR Friederike Middeke, + – Fax: + –
CHMP positive opinion to include RE-CIRCUIT® data for atrial...
www.ansamed.info
Boehringer Ingelheim GmbH. Corporate Communications Media + PR Friederike Middeke Phone: + – Fax: + –
sortiert nach Relevanz / Datum